Straumann Holding stock
Price history
+10.87% over the period1 year: from CHF 98.22 (November 17, 2025) to CHF 108.90 (November 16, 2026), +10.87%.
Show chart data
Closing prices adjusted for splits: the last close of each month.
| Date | Close |
|---|---|
| November 16, 2026 | CHF 108.90 |
| October 30, 2026 | CHF 97.42 |
| September 30, 2026 | CHF 91.54 |
| August 31, 2026 | CHF 93.90 |
| July 31, 2026 | CHF 99.88 |
| June 30, 2026 | CHF 106.40 |
| May 29, 2026 | CHF 94.72 |
| April 30, 2026 | CHF 84.50 |
| March 31, 2026 | CHF 82.00 |
| February 27, 2026 | CHF 92.60 |
| January 30, 2026 | CHF 93.10 |
| December 30, 2025 | CHF 93.46 |
| November 28, 2025 | CHF 91.60 |
| November 17, 2025 | CHF 98.22 |
At a glance
The company
Develop and sell dental implants, prosthetics, orthodontic solutions and digital equipment for tooth replacement, restoration and correction
Latest results
Quarter to September 30, 2026
TickerLandia's take on Straumann Holding
- Pricier than usual relative to earnings: P/E on the latest fiscal year 49 vs a median of 41 over its last 10 fiscal years.
- Pricier than similar companies: trailing 12-month P/E 47 vs 42 (+12%) in a group of 10.
- Strong point: Profitability (76/100 in its group). Weak point: Growth (29/100).
Analysis calculated by TickerLandia from financial statements and prices, with public rules. Not investment advice. How we analyse stocks
Where the price stands
−1.05% from the 52-week high
Analysts · 20 analysts
Average targetCHF 114.32+5.12% vs. price
Buy 13 · Hold 6 · Sell 1 · Buy
TickerLandia Fingerprint: Straumann Holding
Compared with similar companies: high profitability, high financial strength, and low growth.
Financials and price compared with 34 companies in the medical instruments & supplies industry, worldwide. Momentum and risk compared with 1,160 European stocks.
Pricehigh69
How much it costs relative to what it produces.
Metric Value Position in group Price/sales 6.49 69 Price/book 7.49 75 P/E (trailing 12 months) 46.5 62 Forward P/E 27.8 66 EV/EBITDA 22.8 75 Profitabilityhigh76
How much it earns on revenue and capital.
Metric Value Position in group Operating margin 24.7% 75 Gross margin 69.3% 90 Net margin 14.0% 75 ROE 17.0% 66 ROA 11.0% 75 Earnings stabilityhigh71
How steady its margins were over the last five annual reports.
Metric Value Position in group Margin variabilitycounts in reverse: lower means more earnings stability 1.6% 78 Loss-making yearscounts in reverse: lower means more earnings stability 0 of 5 annual reports 63 Growthlow29
How fast revenue and earnings are growing.
Metric Value Position in group Earnings growth (year over year) +5.80% 29 Average revenue growth (3 years) +3.93% 31 Revenue growth (year over year) +2.30% 28 Financial strengthhigh71
How well it would weather a hard period: debt, liquidity, interest.
Metric Value Position in group Interest coverage 44.9 85 Current ratio 2.26 60 Debt/equitycounts in reverse: lower means more financial strength 0.21 71 Net debt/EBITDAcounts in reverse: lower means more financial strength · more cash than debt −0.08 68 Dividendaverage56
How much it returns to shareholders, and for how long.
Metric Value Position in group Consecutive dividend years at least 28 years 83 Dividend yield 0.9% 33 Payout ratio 43.3% 52 Market momentumstrong63
How the stock has moved compared with the market.
Metric Value Position in group Relative strength (3 months) +0.66% 53 Relative strength (6 months) +12.24% 79 1-year return +5.20% 41 Distance from 200-day average +13.89% 77 Riskaverage58
How much the price swings.
Metric Value Position in group Volatility (60 days) 26.5% 48 Beta (1 year) 0.99 71 Maximum drawdown (12 months) 25.6% 55
Position in the group from 0 to 100 (100 = highest value): it describes, it does not rate. Tap a row for the metrics. Calculated on November 16, 2026. An indicator calculated by TickerLandia from financial statements and market data. How it is calculated
Valuation
Straumann Holding is pricier than in the past and pricier than similar companies
On the latest fiscal year's earnings (2025), Straumann Holding's P/E today is 48.8, above the median of its last 10 fiscal years (40.9; between 27.2 and 180.0 from 2016 to 2025). Straumann Holding's P/E (trailing 12 months): 47.1, +12% against the median of a group of 10 similar companies (41.9).
Compared with 10 similar companies
| Metric | Straumann Holding | Position in the group | Band |
|---|---|---|---|
| P/E (trailing 12 months) | 47.1 | Middle | |
| Forward P/E | 28.1 | Middle | |
| Operating margin | 24.7% | High | |
| ROE | 17.0% | Middle | |
| Debt/equity | 0.21 | Low |
P/E at fiscal year end; today on the latest fiscal year's earnings. Grey band: the middle half of the group; tick: the median; dot: Straumann Holding. All multiples and dividends
TickerLandia analysisHow it is calculated
The financials
The business in numbers
Revenue
CHF 1.38B
Latest quarter · Q2 2026
Net income
CHF 249.7M
Latest quarter · Q2 2026
Quarterly net margin
18.1%
Latest quarter · Q2 2026
Numbers and valuation
Full valuation- Market cap
- CHF 17.35B
- P/E
- 47.1
- EPS
- CHF 2.31
- Volume
- 166.21K
- Daily trading
- €44.93M
- Dividend yield
- 0.92%
- Last ex-dividend on April 21, 2026
How Straumann Holding is changing
All resultsRevenue grew 12.8% a year on average over the last 5 years
Operating margin rose from 23.7% to 25.1%
Profits turn into cash: free cash flow equal to 106% of net income
Returns
Straumann Holding returns with dividends
CHF 1,000 invested in Straumann Holding 5 years ago, on November 16, 2021, would be worth CHF 560 today with dividends reinvested: −44.00% in total, −10.95% per year. On price alone it would be CHF 539 (−46.09%).
| Period | Straumann Holding | SMI | CHF 1,000 becomes |
|---|---|---|---|
| 1 month | +16.07% | +5.87% | CHF 1,161 |
| 6 months | +30.05% | +15.25% | CHF 1,301 |
| Year to date | +16.52% | +14.84% | CHF 1,165 |
| 1 year | +12.11% | +20.94% | CHF 1,121 |
| 3 years | −5.38% | +43.15% | CHF 946 |
| 5 years | −44.00% | +21.33% | CHF 560 |
| 10 years | +226.67% | +92.52% | CHF 3,267 |
Over the last 6 months it has done better than 47% of the stocks in the Healthcare sector.
From 1 year up with dividends reinvested, before taxes; under a year price only. SMI: price only. Calculate your investment
The chart in detail
Straumann Holding: technical analysis
Straumann Holding is in an uptrend: the price is above its 50- and 200-session moving averages, and the 200-session average is rising. The price is 47.6% below its all-time closing high (CHF 207.50, November 4, 2021).
- Trend
- Upward
- RSI (14 sessions)
- 73
- Above 70: a strong rise in a short time
- vs 200-session average
- +15.44%
Active signals
New 52-week high.
RSI above 70: the stock has risen a lot in a short time.
since November 12, 2026
Support and resistance
Price areas where Straumann Holding has stopped several times in the last year. They describe the chart; they are not forecasts.
- ResistanceCHF 109.48+0.67%2 touches, last on November 5, 2026
- Last priceCHF 108.75
- SupportCHF 105.10−3.36%2 touches, last on August 6, 2026
- SupportCHF 102.53−5.72%3 touches, last on July 2, 2026
- SupportCHF 99.76−8.26%2 touches, last on September 28, 2026
Volatility and risk
Over the last year it has moved roughly in line with the SMI.
- Beta (1 year) vs SMI
- 0.98
- Volatility (60 sessions, annualised)
- 26.6%
- Largest fall in the last year
- −24.84%
Close of November 16, 2026. Descriptive data calculated on daily prices: it describes the chart and is not investment advice. Beta and volatility describe the last year and can change a lot from one year to the next. How we calculate it
Straumann Holding: seasonality
Average monthly price change over 29 years
Over the last 29 years, the strongest month for Straumann Holding has been April: +3.66% on average, positive in 18 years out of 28. The weakest has been September: −0.72% on average, positive in 14 years out of 29. November, the current month, has been positive in 18 years out of 28 (+1.43% on average).
Show chart data
| Month | Average | Median | Positive years |
|---|---|---|---|
| January | +1.24% | +0.46% | 15 of 28 |
| February | +2.41% | +1.62% | 16 of 28 |
| March | +0.16% | +1.69% | 16 of 28 |
| April | +3.66% | +1.72% | 18 of 28 |
| May | +2.58% | +2.49% | 18 of 28 |
| June | +0.91% | +1.30% | 15 of 28 |
| July | +1.11% | −0.01% | 14 of 28 |
| August | +2.07% | +1.74% | 17 of 29 |
| September | −0.72% | −0.46% | 14 of 29 |
| October | +1.69% | +2.80% | 17 of 29 |
| November | +1.43% | +3.06% | 18 of 28 |
| December | +3.39% | +1.23% | 17 of 28 |
Price change only, dividends excluded. Past seasonality does not predict future moves.
The company
Straumann Holding and its competitors
Tooth replacement is the starting point of the business, with dental implants, implant components and surgical instruments sold alongside prosthetics, CADCAM solutions and digital equipment such as intraoral scanners and 3D printers. Orthodontic products, including clear aligners sold under ClearCorrect, form a second area, while regenerative materials, consumables and training complete the range.
- Headquarters
- Basel, Switzerland
- Employees
- 11,582
- Founded
- 1954
- Chief executive
- Guillaume Daniellot
| Company | Market cap | Operating margin | P/E (trailing 12 months) | 6 months |
|---|---|---|---|---|
| Straumann HoldingSTMN | $20.69B | 24.7% | 47.1 | +30.05% |
| Sartorius Stedim BiotechDIM | $24B | 19.2% | 67.0 | +44.45% |
| SartoriusSRT | $19.89B | 17.8% | 79.3 | +37.44% |
| ColoplastCOLO.B | $16.93B | 25.7% | 37.2 | +27.77% |
| AlconALC | $35.8B | 12.9% | 57.3 | +23.24% |
| Ypsomed HoldingYPSN | $6.77B | 36.2% | 34.3 | +44.57% |
Same industry or related industries, similar size. Compare Straumann Holding with its competitors · Full profile
